Cellular uptake of saposin (SAP) precursor and lysosomal delivery by the low density lipoprotein receptor-related protein (LRP)

EMBO Journal

Volumn 17, Issue 16, 1998, Pages 4617-4625

  Hiesberger, Thomas ^a   Hüttler, Silke ^b   Rohlmann, Astrid ^a   Schneider, Wolfgang ^b   Sandhoff, Konrad ^b   Herz, Joachim ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NONE

Author keywords

Endocytosis; Lipoprotein receptor related protein; Mannose 6 phosphate; Saposin; Sphingolipid

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR; PROTEIN PRECURSOR; RECEPTOR PROTEIN; SOMATOMEDIN B RECEPTOR; SPHINGOLIPID ACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; CELL MEMBRANE TRANSPORT; CELL SECRETION; ENDOCYTOSIS; INTERNALIZATION; LYSOSOME; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT;

ANIMALS; BASE SEQUENCE; CELL LINE; DNA PRIMERS; ENDOCYTOSIS; GLYCOPROTEINS; HUMANS; LDL-RECEPTOR RELATED PROTEIN 1; LYSOSOMES; MICE; PROTEIN PRECURSORS; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LDL; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0032541422     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/17.16.4617     Document Type: Article

References (43)

1. Bradova,V., Smid,F., Ulrich-Bott,B., Roggendorf,W., Paton,B.C. and Harzer,K. (1993) Prosaposin deficiency: further characterization of the sphingolipid activator protein-deficient sibs. Multiple glycolipid elevations (including lactosylceramidosis), partial enzyme deficiencies and ultrastructure of the skin in this generalized sphingolipid storage disease. Hum. Genet., 92, 143-152.
2. Fraker,P.J. and Speck,J.C. (1978) Protein and cell membrane iodinations with a sparingly soluble chloroarnide, l,3,4,6-tetrachloro-3a,6a-diphenylglycoluril. Biochem. Biophys. Res. Comm., 80, 849-857.
3. Fujita,N. et al. (1996) Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids. Hum. Mol. Genet., 5, 711-725.
4. Goldstein,J.L., Basu,S.K. and Brown,M.S. (1983) Receptor-mediated endocytosis of LDL in cultured cells. Methods Enzymol., 98, 241-260.
5. Harzer,K., Paton,B.C. Poulos,A., Kustermann-Kuhn,B., Roggendorf,W., Grisar,T. and Popp,M. (1989) Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidoses. Eur. J. Pediatr., 149, 31-39.
6. Hasilik,A. and Neufeld,E.F. (1980) Biosynthesis of lysosomal enzymes in fibroblasts. Phosphorylation of mannose residues. J. Biol Chem., 255, 4946-4950.
7. Henseler,M., Klein,A., Reber,M., Vanier,M.T., Landrieu,P. and Sandhoff,K. (1996) Analysis of a splice-site mutation in the SAP precursor gene of a patient with metachromatic leukodystrophy. Am. J. Hum. Genet., 58, 65-74.
8. Herz,J., Goldstein,J.L., Strickland,D.K., Ho,Y.K. and Brown,M.S. (1991) 39-kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/α2-macroglobulin receptor. J. Biol. Chem., 266, 21232-21238.
9. Herz,J., Qiu,S.Q., Oesterle,A., DeSilva,H.V., Shafi,S. and Havel,R.J. (1995) Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor. Proc. Natl Acad. Sci. USA. 92, 4611-4615.
10. Hickman,S. and Neufeld,E.F. (1972) A hypothesis for I-cell disease: defective hydrolases that do not enter lysosomes. Biochem. Biophys. Res. Commun., 49, 992-999.
11. Hineno,T., Sano,A., Kondoh,K., Ueno,S., Kakimoto,Y. and Yoshida,K. (1991) Secretion of sphingolipid hydrolase activator precursor, prosaposin. Biochem. Biophys. Res. Commun., 176, 668-674.
12. Hiraiwa,M., Soeda,S., Kishimoto,Y. and O'Brien,J.S. (1992) Binding and transport of gangliosides by prosaposin. Proc. Natl Acad. Sci. USA, 89, 11254-11258.
13. Hiraiwa,M., Taylor,E.M., Campana,W.M., Darin,S.J. and O'Brien,J.S. (1997) Cell death prevention, mitogen-activated protein kinase stimulation and increased sulfatide concentrations in Schwann cells and oligodendrocytes by prosaposin and prosaptides. Proc. Natl Acad. Sci. USA, 94, 4778-4781.
14. Kishimoto,Y., Hiraiwa,M. and O'Brien,J.S. (1992) Saposins: structure, function, distribution and molecular genetics. J. Lipid Res., 33, 1255-1267.
15. Kornfeld,S. and Mellman,I. (1989) The biogenesis of lysosomes. Annu. Rev. Cell. Biol., 5, 483-525.
16. Kotani,Y., Matsuda,S., Wen,T.C., Sakanaka,M., Tanaka,J., Maeda,N., Kondoh,K., Ueno,S. and Sano,A. (1996) A hydrophilic peptide comprising 18 amino acid residues of the prosaposin sequence has neurotrophic activity in vitro and in vivo. J. Neurochem., 66, 2197-2200.
17. Kowal,R.C., Herz,J., Goldstein,J.L., Esser,V. and Brown,M.S. (1989) Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins. Proc. Natl Acad. Sci. USA, 86, 5810-5814.
18. Kowal,R.C., Herz,J., Mahley,R.W., Brown,M.S. and Goldstein,J.L. (1990) Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein. J. Biol. Chem., 265, 10771-10779.
19. Krieger,M. and Herz,J. (1994) Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu. Rev. Biochem., 63, 601-637.
20. Lindstedt,K.A., Bujo,H., Mahon,M.G., Nimpf,J. and Schneider,W.J. (1997) Germ cell-somatic cell dichotomy of a low-density lipoprotein receptor gene family member in testis. DNA Cell. Biol., 16, 35-43.
21. Morgan,D.O., Edman,J.C., Standring,D.N., Fried,V.A., Smith,M.C., Roth,R.A. and Rutter,W.J. (1987) Insulin-like growth factor II receptor as a multifunctional binding protein [published erratum appears in Nature 1988 July, 20 (7):442]. Nature, 329, 301-307.
22. O'Brien,J.S., Carson,G.S., Seo,H.C., Hiraiwa,M. and Kishimoto,Y. (1994) Identification of prosaposin as a neurotrophic factor. Proc. Natl Acad. Sci. USA, 91, 9593-9596.
23. Orth,K., Madison,E.L., Gething,M.-J., Sambrook,J.F. and Herz,J. (1992) Complexes of t-PA and its serpin inhibitor PAI-1 are internalized via the LRP/a2-macroglobulin receptor. Proc. Natl Acad. Sci. USA, 89, 7422-7426.
24. Paton,B.C., Hughes,J.L., Harzer,K. and Poulos,A. (1990) Immunocytochemical localization of sphingolipid activator protein 2 (SAP-2) in normal and SAP-deficient fibroblasts. Eur. J. Cell. Biol., 51, 157-164.
25. Paton,B.C., Schmid,B., Kustermann-Kuhn,B., Poulos,A. and Harzer,K. (1992) Additional biochemical findings in a patient and fetal sibling with a genetic defect in the sphingolipid activator protein (SAP) precursor, prosaposin. Evidence for a deficiency in SAP-1 and for a normal lysosomal neuraminidase. Biochem. J., 285, 481-488.
26. Rafi,M.A., Zhang,X.L., DeGala,G. and Wenger,D.A. (1990) Detection of a point mutation in sphingolipid activator protein-1 mRNA in patients with a variant form of metachromatic leukodystrophy. Biochem. Biophys. Res. Commun., 166, 1017-1023.
27. Rafi,M.A., de Gala,G., Zhang,X.L. and Wenger,D.A. (1993) Mutational analysis in a patient with a variant form of Gaucher disease caused by SAP-2 deficiency. Somat. Cell. Mol. Genet., 19, 1-7.
28. Rohlmann,A., Gotthardt,M., Willnow,T.E., Hammer,R.H. and Herz,J. (1996) Sustained somatic gene inactivation by viral transfer of Cre recombinase. Nature Biotechnol., 14, 1562-1565.
29. Rohlmann,A., Gotthardt,M., Hammer,R.E. and Herz,J. (1998) Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants. J. Clin. Invest., 101, 689-695.
30. Sandhoff,K. and Kolter,T. (1996) Topology of glycosphingolipid degradation. Trends Cell. Biol., 6, 98-103.
31. Sandhoff,K. and Kolter,T. (1997) Biochemistry of glycosphingolipid degradation. Clin. Chim. Acta, 266, 51-61.
32. Sandhoff,K., Harzer,K. and Furst,W. (1995) Sphingolipid activator proteins. In Scriver,C.R. Beaudet.A.L., Sly.W.S. and Valle,D. (eds), The Metabolic and Molecular Basis of Inherited Disease. McGraw-Hill, New York, NY, pp. 2427-2441.
33. Schmid,B., Paton,B.C., Sandhoff,K. and Harzer,K. (1992) Metabolism of GM1 ganglioside in cultured skin fibroblasts: anomalies in gangliosidoses, sialidoses and sphingolipid activator protein (SAP, saposin) 1 and prosaposin deficient disorders. Hum. Genet., 89, 513-518.
34. Schnabel,D., Schroder,M. and Sandhoff,K. (1991) Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease. FEBS Lett., 284, 57-59.
35. Stahl,P.D. and Schlesinger,P.H. (1980) Receptor-mediated pinocytosis of mannose/N-acetylglucosamine-terminated glycoproteins and lysosomal enzymes by macrophages. Trends Biochem. Sci., 5, 194-196.
36. Vaccaro,A.M., Tatti,M., Ciaffoni,F., Salvioli,R., Barca,A. and Scerch,C. (1997) Effect of saposins A and C on the enzymatic hydrolysis of liposomal glucosylceramide. J. Biol. Client., 272. 16862-16867.
37. van Dongen,J.M., Willemsen,R., Ginns,E.I., Sips,H.J., Tager,J.M., Barranger,J.A. and Reuser,A.J. (1985) The subcellular localization of soluble and membrane-bound lysosomal enzymes in I-cell fibroblasts: a comparative immunocytochemical study. Eur. J. Cell. Biol., 39, 179-189.
38. Varki,A.P., Reitman,M.L. and Kornfeld,S. (1981) Identification of a variant of mucolipidosis III (pseudo-Hurler polydystrophy): a catalytically active W-acetylglucosaminylphosphotransferase that fails to phosphorylate lysosomal enzymes. Proc. Natl Acad. Sci. USA, 78, 7773-7777.
39. Vielhaber,G., Hurwitz,R. and Sandhoff,K. (1996) Biosynthesis, processing and targeting of sphingolipid activator protein (SAP) precursor in cultured human fibroblasts, Mannose 6-phosphate receptor-independent endocytosis of SAP precursor. J. Biol. Chem., 271, 32438-32446.
40. Weiler, S., Kishimoto,Y., O'Brien,J.S., Barranger,J.A. and Tomich,J.M. (1995) Identification of the binding and activating sites of the sphingolipid activator protein, saposin C, with glucocerebrosidase. Protein Sci., 4, 756-764.
41. Willnow,T.E. and Herz, J. (1994) Genetic deficiency in low density lipoprotein receptor-related protein (LRP) confers cellular resistance to pseudomonas exotoxin A - evidence that LRP is required for uptake and degradation of multiple ligands. J. Cell Sci., 107, 719-726.
42. Zhang,X.L., Rafi,M.A., DeGala,G. and Wenger,D.A. (1990) Insertion in the mRNA of a metachromatic leukodystrophy patient with sphingolipid activator protein-1 deficiency. Proc. Natl Acad. Sci. USA, 87, 1426-1430.
43. Zhang,X.L., Rafi,M.A., DeGala,G. and Wenger,D.A. (1991) The mechanism for a 33-nucleotide insertion in mRNA causing sphingolipid activator protein (SAP-1)-deficient metachromatic leukodystrophy. Hum. Genet., 87, 211-215.